News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arena Pharmaceuticals, Inc. (ARNA) Transfers Diet Pill Application to Eisai Company, Ltd. (ESALY.PK)



7/31/2012 7:04:06 AM

Arena Pharmaceuticals Inc. said Monday it transferred marketing rights for the diet pill Belviq to its partner Eisai Co. Ltd., which will market the drug in the U.S. and apply for approval in other North and South American countries. Arena said it transferred the FDA application for the drug to the Japanese pharmaceutical company, which plans to submit it for approval in Mexico, Brazil, Canada and other countries. The FDA approved Belviq in late June for adults who are obese or are overweight with at least one medical complication, such as diabetes or high cholesterol. It was the first FDA approval of a new drug for long-term weight loss in 13 years.

Read at BusinessWeek
Read at Seeking Alpha
Read at Market Watch
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES